David E. Kandzari, MD, FACC, FSCAI

Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States

Dr. David E. Kandzari is the Director, Interventional Cardiology and Chief Scientific Officer the Piedmont Heart Institute in Atlanta, Georgia. Dr. Kandzari specializes in cardiovascular disease, peripheral arterial disease and interventional cardiology. A graduate of Duke University School of Medicine, he completed his internship and residency at The John Hopkins University School of Medicine in Baltimore, Maryland. Following his residency, he completed his general and interventional cardiology fellowship at Duke University where he joined the faculty as the John B. Simpson Assistant Professor of Interventional Cardiology and Genomic Sciences. Dr. Kandzari has held national and international leadership roles in clinical trials in cardiovascular disease and has participated in national and international program committees in cardiology.

Presentation(s):

• Trans-Atlantic Partnership and Future Directions

  Saturday, February 25, 2023
  4:55 PM – 5:00 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• LATE-BREAKING TRIALS | SESSION ONE

  Saturday, February 25, 2023
  4:30 PM – 5:30 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents In US Patients Undergoing Coronary Revascularization: 1-year Outcomes from the BIOFLOW-VII Trial

  Saturday, February 25, 2023
  3:12 PM – 3:20 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• High-Risk PCI | Sunday Session (Non-CME)

  Sunday, February 26, 2023
  8:00 AM – 12:30 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• HIGH-RISK PCI | MCS SUPPORT

  Sunday, February 26, 2023
  8:00 AM – 10:00 AM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Live Case from Medstar Washington Hospital Center | Washington, DC

  Sunday, February 26, 2023
  8:00 AM – 8:45 AM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• The Surgical Turndown Patient: Current Options and Data

  Sunday, February 26, 2023
  9:33 AM – 9:41 AM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Panel Discussion | Who Should get MCS for High-Risk PCI and with Which Device?

  Sunday, February 26, 2023
  9:41 AM – 10:00 AM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Renal Denervation and Hypertension Therapies (Non-CME)

  Sunday, February 26, 2023
  8:00 AM – 12:00 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Panel Discussion: Best Practice for Establishing a HTN Patient Care Medical Based Pathway

  Sunday, February 26, 2023
  10:15 AM – 10:30 AM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Deep Dive Into the Results of the SPYRAL Hypertension Program (OFF-MED and ON-MED Trials)

  Sunday, February 26, 2023
  10:46 AM – 10:54 AM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• Panel Discussion | Future of Renal Denervation Studies and Clinical Implementation

  Sunday, February 26, 2023
  11:50 AM – 12:00 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)

• High-Risk PCI | Monday Session (Non-CME)

  Monday, February 27, 2023
  10:00 AM – 12:00 PM ET

  Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)